Companies: 10,795·Total market cap: $144.5T
Dynavax Technologies Corporation

Dynavax Technologies Corporation

DVAXNASDAQHealthcare
$15.50
+$0.00(+0.00%)
Market Cap$1.8B
P/E Ratio
52W High$15.73
52W Low$9.2

Dynavax Technologies Corporation (DVAX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · DVAX · as of Jun 8, 2026

Activity summary

Buy transactions

1

P-Purchase only

Sell transactions

4

12 Months

Buy/Sell ratio

0.25

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 20%Active transactions only · RSU vesting excluded80% Sell ↓

Dynavax Technologies Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

DVAX insider buying and selling by quarter

DVAX insider selling · DVAX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
22.0M11.0M0
2025 Q2
2025 Q3
2025 Q4
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · DVAX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

DVAX executive sell shares · DVAX board member insider trading · DVAX insider trading SEC filing

Showing 14 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Spencer Ryan

CEO and Director

Other

Date

Feb 10

Shares

379,620

Price

Value

View Form 4 on SEC.gov

Slebir John L

SVP General Counsel

Other

Date

Feb 10

Shares

69,634

Price

Value

View Form 4 on SEC.gov

Metzinger Joseph Anthony

VP, Chief Accounting Officer

Other

Date

Feb 10

Shares

7,129

Price

Value

View Form 4 on SEC.gov

MacDonald Kelly

SVP and CFO

Other

Date

Feb 10

Shares

60,204

Price

Value

View Form 4 on SEC.gov

Myers Scott Dunseth

Director

Other

Date

Feb 10

Shares

3,800

Price

Value

View Form 4 on SEC.gov

KISNER DANIEL L

Director

Other

Date

Feb 10

Shares

1,500

Price

Value

View Form 4 on SEC.gov

Novack David F

President & COO

Other

Date

Feb 10

Shares

63,334

Price

Value

View Form 4 on SEC.gov

Novack David F

President & COO

Option

Date

Jan 15

Shares

94,000

Price

$10.47

Value

$984K

View Form 4 on SEC.gov

Novack David F

President & COO

Option

Date

Jan 15

Shares

20,000

Price

$6.80

Value

$136K

View Form 4 on SEC.gov

Novack David F

President & COO

Sale

Date

Jan 15

Shares

114,000

Price

$15.64

Value

$1.78M ⚡

View Form 4 on SEC.gov

MacDonald Kelly

SVP and CFO

Option

Date

Dec 23

Shares

14,141

Price

Value

View Form 4 on SEC.gov

MacDonald Kelly

SVP and CFO

Option

Date

Dec 23

Shares

15,477

Price

Value

View Form 4 on SEC.gov

MacDonald Kelly

SVP and CFO

Award

Date

Dec 23

Shares

37,500

Price

Value

View Form 4 on SEC.gov

MacDonald Kelly

SVP and CFO

Other

Date

Dec 24

Shares

36,141

Price

$15.38

Value

$556K

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About DVAX insider trading

DVAX insider trades

Dynavax Technologies Corporation (DVAX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including MacDonald Kelly (SVP and CFO), Novack David F (President & COO), Spencer Ryan (CEO and Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. DVAX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Dynavax Technologies Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

DVAX insider trading · 5 questions

The insiders of Dynavax Technologies Corporation (DVAX) include executives and directors such as MacDonald Kelly (SVP and CFO), Novack David F (President & COO), Spencer Ryan (CEO and Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

DVAX board member insider tradingwho are DVAX insidersDVAX insider rosterDynavax Technologies Corporation executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026